Glutamate modulation of antinociception, but not tolerance, produced by morphine microinjection into the periaqueductal gray of the rat

Brain Research

Volumn 1295, Issue , 2009, Pages 59-66

  Morgan, Michael M ^a   Bobeck, Erin N ^a   Ingram, Susan L ^a  

^a WASHINGTON STATE UNIVERSITY   (United States)

Author keywords

Analgesia; Morphine tolerance; NMDA receptor; Opioid; Pain modulation

Indexed keywords

DIZOCILPINE; KYNURENIC ACID; MORPHINE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTINOCICEPTION; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFECT; DRUG MECHANISM; MALE; NEUROMODULATION; NONHUMAN; PERIAQUEDUCTAL GRAY MATTER; PRIORITY JOURNAL; RAT;

ANALGESIA; ANALGESICS, OPIOID; ANALYSIS OF VARIANCE; ANIMALS; DIZOCILPINE MALEATE; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG INTERACTIONS; DRUG TOLERANCE; EXCITATORY AMINO ACID ANTAGONISTS; GLUTAMIC ACID; HOT TEMPERATURE; KYNURENIC ACID; MALE; MICROINJECTIONS; MORPHINE; PAIN; PAIN MEASUREMENT; PERIAQUEDUCTAL GRAY; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, GLUTAMATE; RECEPTORS, OPIOID, MU; STAINING AND LABELING;

RATTUS;

EID: 70349255508     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.brainres.2009.07.100     Document Type: Article

References (66)

1. Albin R.L., Makowiec R.L., Hollingsworth Z., Dure L.S.t., Penney J.B., and Young A.B. Excitatory amino acid binding sites in the periaqueductal gray of the rat. Neurosci. Lett. 118 (1990) 112-115
2. Allen R.M., and Dykstra L.A. N-methyl-d-aspartate receptor antagonists potentiate the antinociceptive effects of morphine in squirrel monkeys. J. Pharmacol. Exp. Ther. 298 (2001) 288-297
3. Behbehani M.M., and Fields H.L. Evidence that an excitatory connection between the periaqueductal gray and nucleus raphe magnus mediates stimulation produced analgesia. Brain Res. 170 (1979) 85-93
4. Beitz A.J. Relationship of glutamate and aspartate to the periaqueductal gray-raphe magnus projection: analysis using immunocytochemistry and microdialysis. J. Histochem. Cytochem. 38 (1990) 1755-1765
5. Bernal S.A., Morgan M.M., and Craft R.M. PAG mu opioid receptor activation underlies sex differences in morphine antinociception. Behav. Brain Res. 177 (2007) 126-133
6. Berrino L., Oliva P., Rossi F., Palazzo E., Nobili B., and Maione S. Interaction between metabotropic and NMDA glutamate receptors in the periaqueductal grey pain modulatory system. Naunyn. Schmiedebergs. Arch. Pharmacol. 364 (2001) 437-443
7. Bespalov A., Kudryashova M., and Zvartau E. Prolongation of morphine analgesia by competitive NMDA receptor antagonist D-CPPene (SDZ EAA 494) in rats. Eur. J. Pharmacol. 351 (1998) 299-305
8. Bulka A., Wiesenfeld-Hallin Z., and Xu X.J. Differential antinociception by morphine and methadone in two sub-strains of Sprague-Dawley rats and its potentiation by dextromethorphan. Brain Res. 942 (2002) 95-100
9. Chieng B., and Christie M.J. Inhibition by opioids acting on mu-receptors of GABAergic and glutamatergic postsynaptic potentials in single rat periaqueductal gray neurones in vitro. Br. J. Pharmacol. 113 (1994) 303-309
10. Clements J.R., Madl J.E., Johnson R.L., Larson A.A., and Beitz A.J. Localization of glutamate, glutaminase, aspartate and aspartate aminotransferase in the rat midbrain periaqueductal gray. Exp. Brain. Res. 67 (1987) 594-602
11. Commons K.G., van Bockstaele E.J., and Pfaff D.W. Frequent colocalization of mu opioid and NMDA-type glutamate receptors at postsynaptic sites in periaqueductal gray neurons. J. Comp. Neurol. 408 (1999) 549-559
12. Craft R.M., and Lee D.A. NMDA antagonist modulation of morphine antinociception in female vs. male rats. Pharmacol. Biochem. Behav. 80 (2005) 639-649
13. Depaulis A., Morgan M.M., and Liebeskind J.C. GABAergic modulation of the analgesic effects of morphine microinjected in the ventral periaqueductal gray matter of the rat. Brain Res. 436 (1987) 223-228
14. Fields H.L., Bry J., Hentall I., and Zorman G. The activity of neurons in the rostral medulla of the rat during withdrawal from noxious heat. J. Neurosci. 3 (1983) 2545-2552
15. Fischer B.D., Carrigan K.A., and Dykstra L.A. Effects of N-methyl-d-aspartate receptor antagonists on acute morphine-induced and l-methadone-induced antinociception in mice. J. Pain. 6 (2005) 425-433
16. Fossum E.N., Lisowski M.J., Macey T.A., Ingram S.L., and Morgan M.M. Microinjection of the vehicle dimethyl sulfoxide (DMSO) into the periaqueductal gray modulates morphine antinociception. Brain Res. 1204 (2008) 53-58
17. He L., Fong J., von Zastrow M., and Whistler J.L. Regulation of opioid receptor trafficking and morphine tolerance by receptor oligomerization. Cell 108 (2002) 271-282
18. Heinricher M.M., Morgan M.M., and Fields H.L. Direct and indirect actions of morphine on medullary neurons that modulate nociception. Neuroscience 48 (1992) 533-543
19. Heinricher M.M., Morgan M.M., Tortorici V., and Fields H.L. Disinhibition of off-cells and antinociception produced by an opioid action within the rostral ventromedial medulla. Neuroscience 63 (1994) 279-288
20. Heinricher M.M., McGaraughty S., and Farr D.A. The role of excitatory amino acid transmission within the rostral ventromedial medulla in the antinociceptive actions of systemically administered morphine. Pain 81 (1999) 57-65
21. Heinricher M.M., Schouten J.C., and Jobst E.E. Activation of brainstem N-methyl-d-aspartate receptors is required for the analgesic actions of morphine given systemically. Pain 92 (2001) 129-138
22. Ingram S.L., Vaughan C.W., Bagley E.E., Connor M., and Christie M.J. Enhanced opioid efficacy in opioid dependence is caused by an altered signal transduction pathway. J. Neurosci. 18 (1998) 10269-10276
23. Ingram S.L., Macey T.A., Fossum E.N., and Morgan M.M. Tolerance to repeated morphine administration is associated with increased potency of opioid agonists. Neuropsychopharmacology 33 (2008) 2494-2504
24. Jacquet Y.F., and Lajtha A. Paradoxical effects after microinjection of morphine in the periaqueductal gray matter in the rat. Science 185 (1974) 1055-1057
25. Jacquet Y.F., and Lajtha A. The periaqueductal gray: site of morphine analgesia and tolerance as shown by 2-way cross tolerance between systemic and intracerebral injections. Brain Res. 103 (1976) 501-513
26. Jacquet Y.F. The NMDA receptor: central role in pain inhibition in rat periaqueductal gray. Eur. J. Pharmacol. 154 (1988) 271-276
27. Jensen T.S., and Yaksh T.L. Comparison of antinociceptive action of morphine in the periaqueductal gray, medial and paramedial medulla in rat. Brain Res. 363 (1986) 99-113
28. Jensen T.S., and Yaksh T.L. The antinociceptive activity of excitatory amino acids in the rat brainstem: an anatomical and pharmacological analysis. Brain Res. 569 (1992) 255-267
29. Kozela E., and Popik P. A complete analysis of NMDA receptor subunits in periaqueductal grey and ventromedial medulla of morphine tolerant mice. Drug Alcohol Depend. 86 (2007) 290-293
30. Lane D.A., and Morgan M.M. Antinociceptive tolerance to morphine from repeated nociceptive testing in the rat. Brain Res. 1047 (2005) 65-71
31. Lane D.A., Patel P.A., and Morgan M.M. Evidence for an intrinsic mechanism of antinociceptive tolerance within the ventrolateral periaqueductal gray of rats. Neuroscience 135 (2005) 227-234
32. Larcher A., Laulin J.P., Celerier E., Le Moal M., and Simonnet G. Acute tolerance associated with a single opiate administration: involvement of N-methyl-d-aspartate-dependent pain facilitatory systems. Neuroscience 84 (1998) 583-589
33. Maione S., Marabese I., Oliva P., de Novellis V., Stella L., Rossi F., and Filippelli A. Periaqueductal gray matter glutamate and GABA decrease following subcutaneous formalin injection in rat. Neuroreport 10 (1999) 1403-1407
34. Maione S., Oliva P., Marabese I., Palazzo E., Rossi F., Berrino L., and Filippelli A. Periaqueductal gray matter metabotropic glutamate receptors modulate formalin-induced nociception. Pain 85 (2000) 183-189
35. Mao J. NMDA and opioid receptors: their interactions in antinociception, tolerance and neuroplasticity. Brain Res. Brain Res. Rev. 30 (1999) 289-304
36. Mao J., Price D.D., Caruso F.S., and Mayer D.J. Oral administration of dextromethorphan prevents the development of morphine tolerance and dependence in rats. Pain 67 (1996) 361-368
37. Marabese I., de Novellis V., Palazzo E., Mariani L., Siniscalco D., Rodella L., Rossi F., and Maione S. Differential roles of mGlu8 receptors in the regulation of glutamate and gamma-aminobutyric acid release at periaqueductal grey level. Neuropharmacology 49 Suppl. 1 (2005) 157-166
38. Mayer D.J., Wolfle T.L., Akil H., Carder B., and Liebeskind J.C. Analgesia from electrical stimulation in the brainstem of the rat. Science 174 (1971) 1351-1354
39. Meyer P.J., Fossum E.N., Ingram S.L., and Morgan M.M. Analgesic tolerance to microinjection of the micro-opioid agonist DAMGO into the ventrolateral periaqueductal gray. Neuropharmacology 52 (2007) 1580-1585
40. Moreau J.L., and Fields H.L. Evidence for GABA involvement in midbrain control of medullary neurons that modulate nociceptive transmission. Brain Res. 397 (1986) 37-46
41. Morgan M.M., and Clayton C.C. Defensive behaviors evoked from the ventrolateral periaqueductal gray of the rat: comparison of opioid and GABA disinhibition. Behav. Brain Res. 164 (2005) 61-66
42. Morgan M.M., Heinricher M.M., and Fields H.L. Circuitry linking opioid-sensitive nociceptive modulatory systems in periaqueductal gray and spinal cord with rostral ventromedial medulla. Neuroscience 47 (1992) 863-871
43. Morgan M.M., Whitney P.K., and Gold M.S. Immobility and flight associated with antinociception produced by activation of the ventral and lateral/dorsal regions of the rat periaqueductal gray. Brain Res. 804 (1998) 159-166
44. Morgan M.M., Clayton C.C., and Lane D.A. Behavioral evidence linking opioid-sensitive GABAergic neurons in the ventrolateral periaqueductal gray to morphine tolerance. Neuroscience 118 (2003) 227-232
45. Morgan M.M., Fossum E.N., Levine C.S., and Ingram S.L. Antinociceptive tolerance revealed by cumulative intracranial microinjections of morphine into the periaqueductal gray in the rat. Pharmacol. Biochem. Behav. 85 (2006) 214-219
46. Ottersen O.P., and Storm-Mathisen J. Glutamate- and GABA-containing neurons in the mouse and rat brain, as demonstrated with a new immunocytochemical technique. J. Comp. Neurol. 229 (1984) 374-392
47. Paxinos G., and Watson S.J. The Rat Brain, in Stereotaxic Coordinates (2005), Academic Press, Sydney
48. Plesan A., Hedman U., Xu X.J., and Wiesenfeld-Hallin Z. Comparison of ketamine and dextromethorphan in potentiating the antinociceptive effect of morphine in rats. Anesth. Analg. 86 (1998) 825-829
49. Renno W.M. Microdialysis of excitatory amino acids in the periaqueductal gray of the rat after unilateral peripheral inflammation. Amino Acids 14 (1998) 319-331
50. Renno W.M., Mullett M.A., and Beitz A.J. Systemic morphine reduces GABA release in the lateral but not the medial portion of the midbrain periaqueductal gray of the rat. Brain Res. 594 (1992) 221-232
51. Reynolds D.V. Surgery in the rat during electrical analgesia induced by focal brain stimulation. Science 164 (1969) 444-445
52. Sandkuhler J., and Gebhart G.F. Relative contributions of the nucleus raphe magnus and adjacent medullary reticular formation to the inhibition by stimulation in the periaqueductal gray of a spinal nociceptive reflex in the pentobarbital-anesthetized rat. Brain Res. 305 (1984) 77-87
53. Sherman A.D., and Gebhart G.F. Pain-induced alteration of glutamate in periaqueductal central gray and its reversal by morphine. Life Sci. 15 (1974) 1781-1789
54. Silva E., Hernandez L., Contreras Q., Guerrero F., and Alba G. Noxious stimulation increases glutamate and arginine in the periaqueductal gray matter in rats: a microdialysis study. Pain 87 (2000) 131-135
55. Siuciak J.A., and Advokat C. Tolerance to morphine microinjections in the periaqueductal gray (PAG) induces tolerance to systemic, but not intrathecal morphine. Brain Res. 424 (1987) 311-319
56. Tallarida R.J. Drug Synergism and Dose-Effect Data Analysis (2000), Chapman & Hall/CRC, Boca Raton
57. Tolle T.R., Berthele A., Zieglgansberger W., Seeburg P.H., and Wisden W. The differential expression of 16 NMDA and non-NMDA receptor subunits in the rat spinal cord and in periaqueductal gray. J. Neurosci. 13 (1993) 5009-5028
58. Tortorici V., Robbins C.S., and Morgan M.M. Tolerance to the antinociceptive effect of morphine microinjections into the ventral but not lateral-dorsal periaqueductal gray of the rat. Behav. Neurosci. 113 (1999) 833-839
59. Tortorici V., Morgan M.M., and Vanegas H. Tolerance to repeated microinjection of morphine into the periaqueductal gray is associated with changes in the behavior of off- and on-cells in the rostral ventromedial medulla of rats. Pain 89 (2001) 237-244
60. Trujillo K.A., and Akil H. Inhibition of morphine tolerance and dependence by the NMDA receptor antagonist MK-801. Science 251 (1991) 85-87
61. Trujillo K.A., and Akil H. Inhibition of opiate tolerance by non-competitive N-methyl-d-aspartate receptor antagonists. Brain Res. 633 (1994) 178-188
62. Urca G., Nahin R.L., and Liebeskind J.C. Glutamate-induced analgesia: blockade and potentiation by naloxone. Brain Res. 192 (1980) 523-530
63. Vaughan C.W., and Christie M.J. Presynaptic inhibitory action of opioids on synaptic transmission in the rat periaqueductal grey in vitro. J. Physiol. 498 Pt. 2 (1997) 463-472
64. Vaughan C.W., Ingram S.L., and Christie M.J. Actions of the ORL1 receptor ligand nociceptin on membrane properties of rat periaqueductal gray neurons in vitro. J. Neurosci. 17 (1997) 996-1003
65. Vaughan C.W., Ingram S.L., Connor M.A., and Christie M.J. How opioids inhibit GABA-mediated neurotransmission. Nature 390 (1997) 611-614
66. Zambotti F., Zonta N., Parenti M., Tommasi R., Vicentini L., Conci F., and Mantegazza P. Periaqueductal gray matter involvement in the muscimol-induced decrease of morphine antinociception. Naunyn. Schmiedebergs. Arch. Pharmacol. 318 (1982) 368-369